Clinical Trials Browser

Phase 2 × OTHER_GOV × Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE × Clear all

NCT07313202 2025-12-31

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

Phase 2 Not yet recruiting

Other solid neoplasm

Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE